Differences in pharmacodynamics but not pharmacokinetics between subjects with panic disorder and healthy subjects after treatment with a single dose of alprazolam / Gary B. Kaplan en Journal of Clinical Psychopharmacology, Año 2000 - Vol. 20 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 3 (Junio) . - pp. 338-346 Título : Differences in pharmacodynamics but not pharmacokinetics between subjects with panic disorder and healthy subjects after treatment with a single dose of alprazolam Tipo de documento: texto impreso Autores: Gary B. Kaplan, Autor ; David J. Greenblatt, Autor ; Bruce L. Ehrenberg, Autor Fecha de publicación: 2023 Artículo en la página: pp. 338-346 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Alprazolam, Ansiolíticos, Electroencefalografía, Trastorno de pánico. Resumen: The pharmacokinetics and pharmacodynamics of the benzodiazepine alprazolam (1 mg, administered orally) were compared between eight patients with panic disorder and eight age- and sex-matched healthy volunteers. Subjects received orally administered placebo and alprazolam in a randomized, double-blind, single-dose crossover study. Link: ./index.php?lvl=notice_display&id=31192 [artículo] Differences in pharmacodynamics but not pharmacokinetics between subjects with panic disorder and healthy subjects after treatment with a single dose of alprazolam [texto impreso] / Gary B. Kaplan, Autor ; David J. Greenblatt, Autor ; Bruce L. Ehrenberg, Autor . - 2023 . - pp. 338-346. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 3 (Junio) . - pp. 338-346 Palabras clave: Alprazolam, Ansiolíticos, Electroencefalografía, Trastorno de pánico. Resumen: The pharmacokinetics and pharmacodynamics of the benzodiazepine alprazolam (1 mg, administered orally) were compared between eight patients with panic disorder and eight age- and sex-matched healthy volunteers. Subjects received orally administered placebo and alprazolam in a randomized, double-blind, single-dose crossover study. Link: ./index.php?lvl=notice_display&id=31192

Differences in pharmacodynamics but not pharmacokinetics between subjects with panic disorder and healthy subjects after treatment with a single dose of alprazolam / Gary B. Kaplan en Journal of Clinical Psychopharmacology, Año 2000 - Vol. 20 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 3 (Junio) . - pp. 338-346 Título : Differences in pharmacodynamics but not pharmacokinetics between subjects with panic disorder and healthy subjects after treatment with a single dose of alprazolam Tipo de documento: texto impreso Autores: Gary B. Kaplan, Autor ; David J. Greenblatt, Autor ; Bruce L. Ehrenberg, Autor Fecha de publicación: 2023 Artículo en la página: pp. 338-346 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Alprazolam, Ansiolíticos, Trastorno de pánico. Resumen: The pharmacokinetics and pharmacodynamics of the benzodiazepine alprazolam (1 mg, administered orally) were compared between eight patients with panic disorder and eight age- and sex-matched healthy volunteers. Subjects received orally administered placebo and alprazolam in a randomized, double-blind, single-dose crossover study. Link: ./index.php?lvl=notice_display&id=31201 [artículo] Differences in pharmacodynamics but not pharmacokinetics between subjects with panic disorder and healthy subjects after treatment with a single dose of alprazolam [texto impreso] / Gary B. Kaplan, Autor ; David J. Greenblatt, Autor ; Bruce L. Ehrenberg, Autor . - 2023 . - pp. 338-346. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 3 (Junio) . - pp. 338-346 Palabras clave: Alprazolam, Ansiolíticos, Trastorno de pánico. Resumen: The pharmacokinetics and pharmacodynamics of the benzodiazepine alprazolam (1 mg, administered orally) were compared between eight patients with panic disorder and eight age- and sex-matched healthy volunteers. Subjects received orally administered placebo and alprazolam in a randomized, double-blind, single-dose crossover study. Link: ./index.php?lvl=notice_display&id=31201

---

1 (1 - 2 / 2)